Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma

Bortezomib-dexamethasone is widely used for relapsed myeloma in routine clinical practice, but comparative data versus single-agent bortezomib are lacking. This retrospective analysis compared second-line treatment with bortezomib-dexamethasone and bortezomib using 109 propensity score-matched pairs...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Haematologica
Autores principales: Dimopoulos, Meletios A., Orlowski, Robert Z., Facon, Thierry, Sonneveld, Pieter, Anderson, Kenneth C., Beksac, Meral, Benboubker, Lotfi, Roddie, Huw, Potamianou, Anna, Couturier, Catherine, Feng, Huaibao, Ataman, Ozlem, van de Velde, Helgi, Richardson, Paul G.
Formato: Artigo
Lenguaje:Inglês
Publicado: Ferrata Storti Foundation 2015
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4281322/
https://ncbi.nlm.nih.gov/pubmed/25261096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.112037
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares